Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MX Orthopedics
Cambridge, Massachusetts, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
MX Orthopedics develops and commercializes orthopedic fracture fixation implants utilizing superelastic Nitinol material. The company's lead product, the dynaMX Compression Staple, received FDA clearance in 2015 for fracture and osteotomy fixation in the hand and foot, as well as proximal tibial metaphysis osteotomy. The dynaMX product line features superelastic legs designed to maintain compression at fracture sites during healing, with a malleable bridge that can be contoured by surgeons to match patient anatomy.[2]
- Therapeutic areas
- RheumatologyOther
- Modalities
- Device
- Industry
- Implantable Medical Devices
Beyond the preview
Go deeper on MX Orthopedics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MX Orthopedics.